TAKE cash flow

Latest FY26

Cash from operations: −₹4.1cr−₹16.4 cr in FY25
Capital spending: ₹0.0crNo figure a year before
Free cash flow: −₹4.1cr−₹16.4 cr in FY25
Cash from financing: −₹0.7cr−₹3.2 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	0.0	0.0	7.9	16.8
	—	0.3	2.0	5.4	7.5
	—	−1.7	−0.2	−0.5	−0.8
	—	0.0	0.0	0.0	0.0
	—	6.6	−11.5	110	58.0
	—	0.0	0.0	0.0	−53.4
	—	9.2	0.0	0.0	−0.2
	—	0.0	0.0	−0.0	0.0
	—	−0.2	0.2	17.2	0.0
	—	−6.1	−11.5	1.7	0.0
	—	−8.8	0.0	0.0	0.0
	—	3.0	2.1	−4.6	24.6
	—	0.0	0.0	0.0	0.0
	—	−0.2	−0.2	−6.2	0.0
	—	−5.8	3.8	5.1	0.0
	—	−4.7	−1.6	−8.7	−27.3
	—	0.0	0.0	0.3	41.5
	—	−0.0	0.0	0.0	0.0
Cash from operating activities
	6.1	4.4	0.7	−118	−45.3
	—	−8.4	−16.8	127	66.8
	—	−4.0	−16.1	8.8	21.5
	—	0.2	0.3	−0.5	1.5
	—	−4.1	−16.4	9.3	20.0
Cash from investing activities
	—	0.0	0.0	7.9	7.8
	—	0.0	0.0	0.1	0.0
	—	0.0	22.0	0.0	29.7
	—	0.0	0.0	0.0	0.5
	—	1.7	0.0	0.0	0.1
	—	0.0	0.2	0.3	−24.7
	—	1.7	22.2	−7.5	−2.1
Cash from financing activities
	—	−0.6	0.0	0.0	0.0
	—	0.0	3.2	5.3	25.3
	—	0.0	0.0	3.0	5.9
	—	0.0	0.0	3.3	4.6
	—	0.0	0.0	0.1	0.1
	—	−0.1	0.0	0.0	0.0
	—	−0.7	−3.2	−11.7	−35.7
	—	−3.1	2.6	−9.9	−17.8
	—	0.0	0.0	0.0	0.0
	—	−3.1	2.6	−9.9	−17.8
	—	—	—	0.8	10.7
Reference items
	−1.7	−1.9	−7.5	−13.5	−19.0
	−2.0%	−3.5%	—	−20.5%	−10.1%
	−4.1	−4.1	−16.4	1.4	12.2
	—	—	—	−7.2	—
	−₹0.28	−₹0.28	−₹1.11	₹0.09	₹0.82
	—	−0.38×	−0.44×	−0.08×	−0.20×
	—	0.2	0.3	−0.5	1.5
	—	—	—	3.3	4.6

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

TAKE₹10.93

TAKE Limited

· Pharma & Health

₹ CrorePeersVIMTALABS SUVENMcap ₹162 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	16.8	7.9	0.0	0.0	—
+ Finance Costs	7.5	5.4	2.0	0.3	—
+ Interest Income	-0.8	-0.5	-0.2	-1.7	—
+ Share-based Payments	0.0	0.0	0.0	0.0	—
+ Other Non-cash Items	58.0	109.5	-11.5	6.6	—
+ Other — Cash Effects are Investing / Financing	-53.4	0.0	0.0	0.0	—
+ Other Reconciling Items	-0.2	0.0	0.0	9.2	—
Changes in Working Capital
+ Inventories	0.0	-0.0	0.0	0.0	—
+ Trade Receivables — Current	0.0	17.2	0.2	-0.2	—
+ Other Financial Assets — Current	0.0	1.7	-11.5	-6.1	—
+ Other Financial Assets — Non-current	0.0	0.0	0.0	-8.8	—
+ Other Current Assets	24.6	-4.6	2.1	3.0	—
+ Other Bank Balances	0.0	0.0	0.0	0.0	—
+ Trade Payables — Current	0.0	-6.2	-0.2	-0.2	—
+ Other Financial Liabilities — Current	0.0	5.1	3.8	-5.8	—
+ Other Current Liabilities	-27.3	-8.7	-1.6	-4.7	—
+ Provisions — Current	41.5	0.3	0.0	0.0	—
+ Provisions — Non-current	0.0	0.0	0.0	-0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	-45.3	-118.4	0.7	4.4	6.1
+ Total Adjustments (incl. Working Capital)	66.8	127.2	-16.8	-8.4	—
Cash from Operations (pre-tax)	21.5	8.8	-16.1	-4.0	—
+ Income Taxes Paid	1.5	-0.5	0.3	0.2	—
Cash from Operating Activities	20.0	9.3	-16.4	-4.1	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	7.8	7.9	0.0	0.0	—
+ Disp of Fixed Assets	0.0	0.1	0.0	0.0	—
+ Disp of Investment Property	29.7	0.0	22.0	0.0	—
+ Disp of Other Long-term Assets	0.5	0.0	0.0	0.0	—
+ Interest Received — Investing	0.1	0.0	0.0	1.7	—
+ Other Inflows / (Outflows) — Investing	-24.7	0.3	0.2	0.0	—
Cash from Investing Activities	-2.1	-7.5	22.2	1.7	—
Cash from Financing Activities
+ Proceeds — Change in Ownership of Subsidiaries	0.0	0.0	0.0	-0.6	—
+ Repayment of Borrowings	25.3	5.3	3.2	0.0	—
+ Payment of Lease Liabilities	5.9	3.0	0.0	0.0	—
+ Interest Paid	4.6	3.3	0.0	0.0	—
+ Dividends Paid	0.1	0.1	0.0	0.0	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	0.0	-0.1	—
Cash from Financing Activities	-35.7	-11.7	-3.2	-0.7	—
Net Changes in Cash (pre-FX)	-17.8	-9.9	2.6	-3.1	—
+ Effect of FX Rate Changes on Cash	0.0	0.0	0.0	0.0	—
Net Changes in Cash	-17.8	-9.9	2.6	-3.1	—
Closing Cash	10.7	0.8	—	—	—
Reference Items
EBITDA	-19.0	-13.5	-7.5	-1.9	-1.7
EBITDA Margin %	-10.07	-20.54	—	-3.53	-2.05
Free Cash Flow (CFO − Capex)	12.2	1.4	-16.4	-4.1	-4.1
Free Cash Flow to Equity	—	-7.2	—	—	—
Free Cash Flow per Basic Share	0.82	0.09	-1.11	-0.28	-0.28
Cash Flow to Net Income	-0.20	-0.08	-0.44	-0.38	—
Cash Paid for Taxes	1.5	-0.5	0.3	0.2	—
Cash Paid for Interest	4.6	3.3	—	—	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.